Alaunos Therapeutics's market cap is currently $5.60M. The company's EPS TTM is $-2.922; its P/E ratio is ―; Alaunos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
